Price
$0.01
Decreased by -5.41%
Dollar volume (20D)
N/A
ADR%
9.90
Shares float
53.70 M
Shares short
110.64 K [0.21%]
Shares outstanding
0.00
Market cap
N/A
Beta
2.12
Price/earnings
N/A

Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility.

Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.

The company was founded in 2019 and is based in San Diego, California.

Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 23 0.00
Decreased by N/A%
1.99 M
Increased by +307.74%
Increased by +N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-2.51 M
Decreased by -716.94%
Decreased by N/A%
-
Mar 31, 23 0.00 - -2.17 M -
Decreased by N/A%
-
Dec 31, 22 0.00 - -3.07 M -
Decreased by N/A%
-
Sep 30, 22 0.00 - -956.00 K -
Decreased by N/A%
-
Mar 31, 22 N/A - -307.00 K - - -
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY